-
Mashup Score: 0Investors tell Silence Therapeutics to shush - 17 hour(s) ago
Silence Therapeutics presented what seemed like positive data on zerlasiran, its experimental drug for reducing cardiovascular risk. Then, its stock fell 36%. What happened?
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Dr. Oz peddles medical misinformation — but could his political rise have a silver lining for public health? - 18 hour(s) ago
Dr. Oz has made a career of peddling misinformation — but he’s also given sound advice on vaccines and masks. Could his political rise have a silver lining for science?
Source: www.statnews.comCategories: General Medicine News, General NewsTweet-
Dr. Oz has peddled medical misinformation — but could his political rise have a silver lining for public health? Read this 2022 story from Lev Facher: https://t.co/zfMIvp1fbB
-
-
Mashup Score: 1What to know about Dr. Oz, Trump's pick to head CMS - 19 hour(s) ago
Today’s health news includes Mehmet Oz as Trump’s pick to oversee Medicare and Medicaid, rising alcohol deaths, and more.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Today's health news: Mehmet Oz is Trump's pick to oversee Medicare and Medicaid, rising alcohol deaths, and more. https://t.co/fNxe3PV6WA
-
-
Mashup Score: 1What records? Chinese company refuses to let FDA inspectors review documents or machinery - 19 hour(s) ago
The FDA maintained that employees refused to provide complete validation reports and production records for a medicine
Source: www.statnews.comCategories: General Medicine News, General NewsTweet-
The FDA maintained that employees refused to provide complete validation reports and production records for a medicine https://t.co/9BbUy39Qvx
-
-
Mashup Score: 0Pharmalittle: We're reading about Pfizer's new R&D head, Merck and J&J job cuts in China, and more - 20 hour(s) ago
Pfizer tapped its chief oncology officer, Chris Boshoff, to head all of its research and development efforts
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Pfizer tapped its chief oncology officer, Chris Boshoff, to head all of its research and development efforts https://t.co/rvlq5nRa1K
-
-
Mashup Score: 3Doubling down on its strategy, Pfizer names its head of oncology as new research chief - 22 hour(s) ago
Pfizer, despite pressure from investors to look outside, elevates its cancer chief Chris Boshoff to lead overall R&D.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Pfizer, despite pressure from investors to look outside, elevates its cancer chief Chris Boshoff to lead overall R&D. https://t.co/8i7lcEchyu
-
-
Mashup Score: 6The term ‘vegetative state’ has no place in modern medicine - 23 hour(s) ago
Opinion: The term “vegetative state” writes off patients as “not even minimally conscious” when medicine is not in a position to make that diagnosis.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Opinion: The term “vegetative state” writes off patients as “not even minimally conscious” when medicine is not in a position to make that diagnosis. https://t.co/8RNgTgX2IV
-
-
Mashup Score: 4Paying a visit to ‘Mom & Dad’s Nipple Factory’ - 24 hour(s) ago
Randi Johnson and her husband set out to create a better prosthetic nipple for people recovering from breast cancer. New FO Podcast:
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Randi Johnson and her husband set out to create a better prosthetic nipple for people recovering from breast cancer. New FO Podcast: https://t.co/P5Ig26zjF6
-
-
Mashup Score: 4New details on a risky medical device show need for more FDA transparency, researchers say - 1 day(s) ago
IVC filters, implants that prevent blood clots, aren’t meant to be permanent — but doctors often forge to retrieve them.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
IVC filters, implants that prevent blood clots, aren't meant to be permanent — but doctors often forge to retrieve them. https://t.co/SMiA2UAPlI
-
-
Mashup Score: 4Pharma still 'falling short' in providing access to low- and middle-income countries, analysis finds - 1 day(s) ago
More pharma companies are tailoring their business models to focus on low-income countries. But a new analysis finds overall industry efforts remain limited.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
More pharma companies are tailoring their business models to focus on low-income countries. But a new analysis finds overall industry efforts remain limited. https://t.co/LNBC1kpYD1
-
Silence Therapeutics presented what seemed like positive data on zerlasiran, its experimental drug for reducing cardiovascular risk. Then, its stock fell 36%. What happened? https://t.co/uwCfbkSRAJ